Clinical Trials on Lymphoproliferative Disorders in New Zealand

Total 16190 results

Intellia Therapeutics

Active, not recruiting

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)

Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac Amyloidosis

France, United Kingdom, New Zealand, Sweden
Syneos Health
Dr. Reddy's Laboratories Limited

Completed

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

Rheumatoid Arthritis | Giant Cell Arteritis

New Zealand, Australia, India
Yale University
Pfizer

Recruiting

Janus Kinase Inhibition in Sarcoidosis

Sarcoidosis

United States
Hoffmann-La Roche

Recruiting

A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

Korea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
University of Cincinnati
Albany Medical College; Foundation for Sarcoidosis Research

Unknown

Patient Reported Outcome Instruments in Sarcoidosis (OSAP-PRO)

Sarcoidosis

United States
Zealand University Hospital

Not yet recruiting

External Validation of Delirium Prediction Models for Intensive Care Patients

Delirium

Denmark
Agios Pharmaceuticals, Inc.

Terminated

A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma

Lymphoma

United States
Bispebjerg Hospital

Completed

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study (CutDM)

Type 2 Diabetes

Denmark
Memorial Sloan Kettering Cancer Center

Completed

Testing a Personalize Medication Log for Patients With Lymphoma

Lymphoma

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.

Completed

Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma

Lymphoma

United States
Roswell Park Cancer Institute

Completed

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Lymphoproliferative Disorder

United States
Arrowhead Pharmaceuticals

Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Dyslipidemias | Hypertriglyceridemia | Familial Hypercholesterolemia

Australia, New Zealand
Neuroscience Trials Australia

Terminated

Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial (EXTEND-IA)

Ischemic Stroke

Australia, New Zealand
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Lymphoma

United States
Dartmouth-Hitchcock Medical Center

Completed

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Lymphoma

United States
HemaQuest Pharmaceuticals Inc.
Boston University

Terminated

Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

EBV Lymphomas | Lympho-proliferative Diseases

United States
Australian and New Zealand Intensive Care Research...
Australian and New Zealand Intensive Care Society Clinical Trials Group

Completed

TEAM: A Trial of Early Activity and Mobility in ICU (TEAM-RCT)

Critically Ill

Australia, New Zealand
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma

Lymphoma, Follicular

Spain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
Hoffmann-La Roche

Terminated

A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants

Non-Hodgkin's Lymphoma

United States, Australia, Korea, Republic of, Germany, New Zealand
Dartmouth-Hitchcock Medical Center

Withdrawn

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Neoplasms | Lymphoma

United States
University of Virginia
Merck Sharp & Dohme LLC

Recruiting

Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above

Classical Hodgkin Lymphoma

United States
Slagelse Hospital
Odense University Hospital; University of Southern Denmark; Region Zealand; Danish...

Completed

Redesign of Everyday Activities and Lifestyle With Occupational Therapy for Chronic Pain Patients (REVEAL(OT))

Chronic Pain

Denmark
University of Michigan Rogel Cancer Center
Bristol-Myers Squibb; Bayer; University of Michigan; Big Ten Cancer Research Consortium

Active, not recruiting

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Indolent Lymphoma

United States
ReCode Therapeutics

Recruiting

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Primary Ciliary Dyskinesia

United Kingdom, United States, Australia, New Zealand
National Center for Complementary and Integrative...

Completed

Meaning-Centered Psychotherapy in Advanced Cancer

Neoplasms | Lymphoma, Non-Hodgkin

United States
AbbVie
Genentech, Inc.

Completed

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199

Non-Hodgkin's Lymphoma

United States
Calithera Biosciences, Inc

Withdrawn

A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

Lymphoma, Malignant | Advanced Solid Neoplasms

United States
Valencia Technologies Corporation

Completed

eCoin Tibial Nerve Stimulation for OAB

Urgency Urinary Incontinence

United States, New Zealand
Memorial Sloan Kettering Cancer Center
MethylGene Inc.

Completed

Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Hodgkin Lymphoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma

Lymphoma

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University; State University of New York -... and other collaborators

Active, not recruiting

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Weill Medical College of Cornell University
Millennium Pharmaceuticals, Inc.

Completed

Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL

Non-Hodgkin's Lymphoma

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Terminated

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Hodgkin Lymphoma

United States
University of Rochester
Massey Cancer Center

Completed

Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma

Lymphoma

United States
University of Copenhagen
Bispebjerg Hospital; Lundbeck Foundation; Region Capital Denmark; Bevica Fonden; Danish... and other collaborators

Completed

Electrical Stimulation of the Paretic Upper Limb in the Early Stroke Phase

Stroke, Acute

Denmark
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC; Syndax Pharmaceuticals

Active, not recruiting

Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas

Lymphoma | Refractory | Relapsed

United States
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute; Thomas Jefferson University; Cornell University

Recruiting

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Lymphoma

United States
Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Completed

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants

Lymphoma, Non-Hodgkin

United States
Sanofi

Completed

Fasturtec TLS Treatment / Prophylysis

Tumor Lysis Syndrome

United States
Roswell Park Cancer Institute
Novartis

Terminated

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma

Lymphoma | Solid Neoplasm

United States
AbbVie
Genentech, Inc.

Completed

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Pfizer

Terminated

Study Evaluating The Safety Of Xyntha In Usual Care Settings

Hemophilia A

United States, New Zealand
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Completed

Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes

Head and Neck Cancers

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Looking at Brain Changes in People With Lymphoma Receiving CAR-T Therapy

Lymphoma Receiving CAR-T Therapy

United States
Memorial Sloan Kettering Cancer Center
Columbia University; University of Vermont; University of Virginia; Northwestern... and other collaborators

Completed

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Lymphoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Memorial Sloan Kettering Cancer Center
Children's Cancer Group

Completed

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Pediatric | Hodgkin's Disease

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma

Lymphoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

Hodgkin's Disease

United States
Zealand University Hospital
Holbaek Sygehus; Chr Hansen; Dept. of Microbiology, Slagelse University Hospital... and other collaborators

Completed

The Effect of Probiotics on Infections in Toddlers

Diarrhoea | Respiratory Diseases

Denmark

Clinical Trials on Lymphoproliferative Disorders in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations